GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Standard BioTools Inc (STU:FLB) » Definitions » Shiller PE Ratio

Standard BioTools (STU:FLB) Shiller PE Ratio : (As of May. 27, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Standard BioTools Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Standard BioTools Shiller PE Ratio Historical Data

The historical data trend for Standard BioTools's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard BioTools Shiller PE Ratio Chart

Standard BioTools Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Standard BioTools Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Standard BioTools's Shiller PE Ratio

For the Diagnostics & Research subindustry, Standard BioTools's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard BioTools's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Standard BioTools's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Standard BioTools's Shiller PE Ratio falls into.



Standard BioTools Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Standard BioTools's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Standard BioTools's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.248/131.7762*131.7762
=-0.248

Current CPI (Mar. 2024) = 131.7762.

Standard BioTools Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.331 100.560 -0.434
201409 -0.380 100.428 -0.499
201412 -0.316 99.070 -0.420
201503 -0.517 99.621 -0.684
201506 -0.472 100.684 -0.618
201509 -0.285 100.392 -0.374
201512 -0.413 99.792 -0.545
201603 -0.620 100.470 -0.813
201606 -0.570 101.688 -0.739
201609 -0.606 101.861 -0.784
201612 -0.578 101.863 -0.748
201703 -0.552 102.862 -0.707
201706 -0.516 103.349 -0.658
201709 -0.386 104.136 -0.488
201712 -0.228 104.011 -0.289
201803 -0.276 105.290 -0.345
201806 -0.360 106.317 -0.446
201809 -0.326 106.507 -0.403
201812 -0.316 105.998 -0.393
201903 -0.389 107.251 -0.478
201906 -0.177 108.070 -0.216
201909 -0.173 108.329 -0.210
201912 -0.164 108.420 -0.199
202003 -0.208 108.902 -0.252
202006 -0.160 108.767 -0.194
202009 -0.068 109.815 -0.082
202012 -0.197 109.897 -0.236
202103 -0.210 111.754 -0.248
202106 -0.191 114.631 -0.220
202109 -0.153 115.734 -0.174
202112 -0.106 117.630 -0.119
202203 -0.899 121.301 -0.977
202206 -0.776 125.017 -0.818
202209 -0.374 125.227 -0.394
202212 -0.245 125.222 -0.258
202303 -0.196 127.348 -0.203
202306 -0.203 128.729 -0.208
202309 -0.253 129.860 -0.257
202312 -0.229 129.419 -0.233
202403 -0.248 131.776 -0.248

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Standard BioTools  (STU:FLB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Standard BioTools Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Standard BioTools's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard BioTools (STU:FLB) Business Description

Traded in Other Exchanges
Address
2 Tower Place, Suite 2000, South San Francisco, CA, USA, 94080
Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Standard BioTools (STU:FLB) Headlines

No Headlines